Tapewire

Nasdaq · USD

VERA

Vera Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4358
SEC CIK
0001831828
Parsed reports
230

Last 12 months

Inside the activity.

1 purchase rows · 33 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202513
Jan 202600
Feb 202607
Mar 202600
Apr 202603
May 202604
Jun 202604
Jul 202608
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 15, 2026 Filed Sep 17, 2026 20:28 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 18,500 $0.00 Strike: $2.90 $0.00
Disclosure

SEC source: 0001859453-26-000015 · form4-09172026_080936.xml · derivative · entry 3

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 488,801

Underlying: Class A Common Stock · 18,500 shares

Expires 2030-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vested monthly thereafter.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:28 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 18,500 $37.00 $684,500.00
Disclosure

SEC source: 0001859453-26-000015 · form4-09172026_080936.xml · nonDerivative · entry 2

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 235,244

F1 · kind: The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 20:28 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
Exercise / conversionClass A Common Stock 18,500 $2.90 $53,590.80
Disclosure

SEC source: 0001859453-26-000015 · form4-09172026_080936.xml · nonDerivative · entry 1

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 253,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 11, 2026 Filed Sep 14, 2026 20:28 UTC
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
Exercise / conversionStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $3.94 $0.00
Disclosure

SEC source: 0001861684-26-000006 · form4-09142026_080921.xml · derivative · entry 2

Young Joseph R · CIK 0001861684 · SVP, FINANCE, CHIEF ACCT OFFCR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,589

Underlying: Class A Common Stock · 5,000 shares

Expires 2031-04-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.

Read SEC document
September 11, 2026 Filed Sep 14, 2026 20:28 UTC
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
Exercise / conversionClass A Common Stock 5,000 $3.94 $19,698.00
Disclosure

SEC source: 0001861684-26-000006 · form4-09142026_080921.xml · nonDerivative · entry 1

Young Joseph R · CIK 0001861684 · SVP, FINANCE, CHIEF ACCT OFFCR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:15 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 18,500 $0.00 Strike: $2.90 $0.00
Disclosure

SEC source: 0001859453-26-000014 · form4-09042026_040901.xml · derivative · entry 3

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 507,301

Underlying: Class A Common Stock · 18,500 shares

Expires 2030-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vested monthly thereafter.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:15 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 18,500 $35.12 $649,642.30
Disclosure

SEC source: 0001859453-26-000014 · form4-09042026_040901.xml · nonDerivative · entry 2

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 235,244

F1 · kind: The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.34, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:15 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
Exercise / conversionClass A Common Stock 18,500 $2.90 $53,590.80
Disclosure

SEC source: 0001859453-26-000014 · form4-09042026_040901.xml · nonDerivative · entry 1

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 253,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:14 UTC
Boman Nancy LeeChief Regulatory Officer
GrantStock Option (right to buy) · Derivative 63,011 $0.00 Strike: $32.23 $0.00
Disclosure

SEC source: 0002145711-26-000002 · form4-08052026_080802.xml · derivative · entry 2

Boman Nancy Lee · CIK 0002145711 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,011

Underlying: Class A Common Stock · 63,011 shares

Expires 2036-08-02

F2 · derivative.exercise_date: 12/48ths of the shares subject to the stock option will vest and become exercisable on August 3, 2027, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:14 UTC
Boman Nancy LeeChief Regulatory Officer
GrantClass A Common Stock 44,987 $0.00 $0.00
Disclosure

SEC source: 0002145711-26-000002 · form4-08052026_080802.xml · nonDerivative · entry 1

Boman Nancy Lee · CIK 0002145711 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,987

F1 · shares: Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2024 Inducement Plan. 1/4th of the RSUs, rounded to the nearest whole share, vest on each of August 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 20:45 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 2,200 $43.59 $95,908.34
Disclosure

SEC source: 0001859453-26-000010 · form4-07092026_040701.xml · nonDerivative · entry 4

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,994

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F5 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.42 to $43.97, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 20:45 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 10,500 $42.86 $450,006.90
Disclosure

SEC source: 0001859453-26-000010 · form4-07092026_040701.xml · nonDerivative · entry 3

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,194

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.40 to $43.38, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 20:45 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 32,550 $42.07 $1,369,495.68
Disclosure

SEC source: 0001859453-26-000010 · form4-07092026_040701.xml · nonDerivative · entry 2

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,694

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.40 to $42.39, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 07, 2026 Filed Jul 9, 2026 20:45 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 1,000 $40.78 $40,776.20
Disclosure

SEC source: 0001859453-26-000010 · form4-07092026_040701.xml · nonDerivative · entry 1

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 197,244

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.39 to $41.31, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
July 07, 2026 Filed Aug 12, 2026 22:42 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 46,250 $0.00 Strike: $2.90 $0.00
Disclosure

SEC source: 0001859453-26-000013 · form4a-08122026_100831.xml · derivative · entry 6

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 525,801

Underlying: Class A Common Stock · 46,250 shares

Expires 2030-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

F7 · derivative.exercise_date: 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vested monthly thereafter.

Read SEC document
July 07, 2026 Filed Aug 12, 2026 22:42 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 2,200 $43.59 $95,908.34
Disclosure

SEC source: 0001859453-26-000013 · form4a-08122026_100831.xml · nonDerivative · entry 5

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 235,244

F2 · kind: The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F6 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.42 to $43.97, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
July 07, 2026 Filed Aug 12, 2026 22:42 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 10,500 $42.86 $450,006.90
Disclosure

SEC source: 0001859453-26-000013 · form4a-08122026_100831.xml · nonDerivative · entry 4

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 237,444

F2 · kind: The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F5 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.40 to $43.38, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
July 07, 2026 Filed Aug 12, 2026 22:42 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 32,550 $42.07 $1,369,495.68
Disclosure

SEC source: 0001859453-26-000013 · form4a-08122026_100831.xml · nonDerivative · entry 3

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 247,944

F2 · kind: The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.40 to $42.39, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
July 07, 2026 Filed Aug 12, 2026 22:42 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 1,000 $40.78 $40,776.20
Disclosure

SEC source: 0001859453-26-000013 · form4a-08122026_100831.xml · nonDerivative · entry 2

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 280,494

F2 · kind: The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.39 to $41.31, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
July 07, 2026 Filed Aug 12, 2026 22:42 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
Exercise / conversionClass A Common Stock 46,250 $2.90 $133,977.00
Disclosure

SEC source: 0001859453-26-000013 · form4a-08122026_100831.xml · nonDerivative · entry 1

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 281,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on July 7, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
June 23, 2026 Filed Jun 24, 2026 20:55 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 88 $38.43 $3,381.84
Disclosure

SEC source: 0001859453-26-000008 · form4-06242026_080643.xml · nonDerivative · entry 2

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,244

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

Read SEC document
June 23, 2026 Filed Jun 24, 2026 20:55 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 18,412 $37.93 $698,387.41
Disclosure

SEC source: 0001859453-26-000008 · form4-06242026_080643.xml · nonDerivative · entry 1

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,332

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.43 to $38.315, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
June 23, 2026 Filed Aug 12, 2026 22:41 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 18,500 $0.00 Strike: $2.90 $0.00
Disclosure

SEC source: 0001859453-26-000012 · form4a-08122026_100823.xml · derivative · entry 4

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 572,051

Underlying: Class A Common Stock · 18,500 shares

Expires 2030-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amended Form 4 is filed to reflect the option exercise that occurred on June 23, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

F4 · derivative.exercise_date: 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vested monthly thereafter.

Read SEC document
June 23, 2026 Filed Aug 12, 2026 22:41 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 88 $38.43 $3,381.84
Disclosure

SEC source: 0001859453-26-000012 · form4a-08122026_100823.xml · nonDerivative · entry 3

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 235,244

F2 · kind: The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on June 23, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
June 23, 2026 Filed Aug 12, 2026 22:41 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 18,412 $37.93 $698,387.41
Disclosure

SEC source: 0001859453-26-000012 · form4a-08122026_100823.xml · nonDerivative · entry 2

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 235,332

F2 · kind: The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.43 to $38.315, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on June 23, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
June 23, 2026 Filed Aug 12, 2026 22:41 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
Exercise / conversionClass A Common Stock 18,500 $2.90 $53,590.80
Disclosure

SEC source: 0001859453-26-000012 · form4a-08122026_100823.xml · nonDerivative · entry 1

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 253,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amended Form 4 is filed to reflect the option exercise that occurred on June 23, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on June 23, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
May 21, 2026 Filed May 26, 2026 20:18 UTC
Hall KimballDirector
GrantStock Option (right to buy) · Derivative 17,084 $0.00 Strike: $34.35 $0.00
Disclosure

SEC source: 0001897965-26-000002 · form4-05262026_080529.xml · derivative · entry 1

Hall Kimball · CIK 0001897965 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,084

Underlying: Class A Common Stock · 17,084 shares

Expires 2036-05-20

F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:22 UTC GrantStock Option (right to buy) · Derivative 17,084 $0.00 Strike: $34.35 $0.00
Disclosure

SEC source: 0001184592-26-000002 · form4-05262026_080559.xml · derivative · entry 1

SEIDENBERG BETH C · CIK 0001184592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,084

Underlying: Class A Common Stock · 17,084 shares

Expires 2036-05-20

F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:17 UTC GrantStock Option (right to buy) · Derivative 17,084 $0.00 Strike: $34.35 $0.00
Disclosure

SEC source: 0001202096-26-000002 · form4-05262026_080523.xml · derivative · entry 1

MORRISSEY MICHAEL · CIK 0001202096 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,084

Underlying: Class A Common Stock · 17,084 shares

Expires 2036-05-20

F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:15 UTC GrantStock Option (right to buy) · Derivative 17,084 $0.00 Strike: $34.35 $0.00
Disclosure

SEC source: 0001253886-26-000004 · form4-05262026_080520.xml · derivative · entry 1

ENRIGHT PATRICK G · CIK 0001253886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,084

Underlying: Class A Common Stock · 17,084 shares

Expires 2036-05-20

F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:19 UTC GrantStock Option (right to buy) · Derivative 17,084 $0.00 Strike: $34.35 $0.00
Disclosure

SEC source: 0001387521-26-000002 · form4-05262026_080541.xml · derivative · entry 1

Meyers James R · CIK 0001387521 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,084

Underlying: Class A Common Stock · 17,084 shares

Expires 2036-05-20

F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:24 UTC GrantStock Option (right to buy) · Derivative 17,084 $0.00 Strike: $34.35 $0.00
Disclosure

SEC source: 0001662426-26-000002 · form4-05262026_080514.xml · derivative · entry 1

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,084

Underlying: Class A Common Stock · 17,084 shares

Expires 2036-05-20

F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:22 UTC
Cheng AndrewDirector
GrantStock Option (right to buy) · Derivative 17,084 $0.00 Strike: $34.35 $0.00
Disclosure

SEC source: 0001778307-26-000002 · form4-05262026_080555.xml · derivative · entry 1

Cheng Andrew · CIK 0001778307 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,084

Underlying: Class A Common Stock · 17,084 shares

Expires 2036-05-20

F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Read SEC document
May 21, 2026 Filed May 26, 2026 20:20 UTC GrantStock Option (right to buy) · Derivative 17,084 $0.00 Strike: $34.35 $0.00
Disclosure

SEC source: 0001822092-26-000005 · form4-05262026_080547.xml · derivative · entry 1

Oliger Christy J. · CIK 0001822092 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,084

Underlying: Class A Common Stock · 17,084 shares

Expires 2036-05-20

F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.

Read SEC document
May 12, 2026 Filed May 13, 2026 20:26 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 4,281 $37.09 $158,768.59
Disclosure

SEC source: 0001859453-26-000007 · form4-05132026_080543.xml · nonDerivative · entry 2

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 216,744

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.97 to $37.15, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 12, 2026 Filed May 13, 2026 20:26 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 14,219 $36.64 $520,978.47
Disclosure

SEC source: 0001859453-26-000007 · form4-05132026_080543.xml · nonDerivative · entry 1

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 221,025

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.96 to $36.94, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 12, 2026 Filed Aug 12, 2026 22:39 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 18,500 $0.00 Strike: $2.90 $0.00
Disclosure

SEC source: 0001859453-26-000011 · form4a-08122026_100809.xml · derivative · entry 4

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 590,551

Underlying: Class A Common Stock · 18,500 shares

Expires 2030-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amended Form 4 is filed to reflect the option exercise that occurred on May 12, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

F5 · derivative.exercise_date: 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vested monthly thereafter.

Read SEC document
May 12, 2026 Filed Aug 12, 2026 22:39 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 4,281 $37.09 $158,768.59
Disclosure

SEC source: 0001859453-26-000011 · form4a-08122026_100809.xml · nonDerivative · entry 3

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 235,244

F2 · kind: The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.97 to $37.15, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on May 12, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
May 12, 2026 Filed Aug 12, 2026 22:39 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 14,219 $36.64 $520,978.47
Disclosure

SEC source: 0001859453-26-000011 · form4a-08122026_100809.xml · nonDerivative · entry 2

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 239,525

F2 · kind: The sales were made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.96 to $36.94, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on May 12, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
May 12, 2026 Filed Aug 12, 2026 22:39 UTC Amendment
Fordyce MarshallDirector · PRESIDENT AND CEO
Exercise / conversionClass A Common Stock 18,500 $2.90 $53,590.80
Disclosure

SEC source: 0001859453-26-000011 · form4a-08122026_100809.xml · nonDerivative · entry 1

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 253,744

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amended Form 4 is filed to reflect the option exercise that occurred on May 12, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

F1 · balance_after: This amended Form 4 is filed to reflect the option exercise that occurred on May 12, 2026 and correct the amounts reported in Column 5 "Amount of Securities Beneficially Owned Following Reported Transaction(s)".

Read SEC document
April 14, 2026 Filed Apr 15, 2026 20:57 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 900 $45.51 $40,960.26
Disclosure

SEC source: 0001859453-26-000006 · form4-04152026_080434.xml · nonDerivative · entry 3

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 235,244

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended,

F5 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.25 to $45.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
April 14, 2026 Filed Apr 15, 2026 20:57 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 7,921 $44.58 $353,105.51
Disclosure

SEC source: 0001859453-26-000006 · form4-04152026_080434.xml · nonDerivative · entry 2

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 236,144

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended,

F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.25 to $45.20, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
April 14, 2026 Filed Apr 15, 2026 20:57 UTC
Fordyce MarshallDirector · PRESIDENT AND CEO
SaleClass A Common Stock 14,130 $43.66 $616,985.04
Disclosure

SEC source: 0001859453-26-000006 · form4-04152026_080434.xml · nonDerivative · entry 1

Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 244,065

F1 · kind: This sale was made pursuant to a written plan adopted on January 9, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended,

F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.25 to $44.24, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 1,032 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2026.

Read SEC document
March 23, 2026 Filed Mar 25, 2026 19:08 UTC
Wright-Mitchell JaneChief Legal Officer
GrantStock Option (right to buy) · Derivative 56,850 $0.00 Strike: $40.73 $0.00
Disclosure

SEC source: 0001614568-26-000008 · form4-03252026_110324.xml · derivative · entry 2

Wright-Mitchell Jane · CIK 0001614568 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,850

Underlying: Class A Common Stock · 56,850 shares

Expires 2036-03-22

F2 · derivative.exercise_date: 12/48ths of the shares subject to the stock option will vest and become exercisable on March 23, 2027, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
March 23, 2026 Filed Mar 25, 2026 19:08 UTC
Wright-Mitchell JaneChief Legal Officer
GrantClass A Common Stock 42,403 $0.00 $0.00
Disclosure

SEC source: 0001614568-26-000008 · form4-03252026_110324.xml · nonDerivative · entry 1

Wright-Mitchell Jane · CIK 0001614568 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,403

F1 · shares: Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2024 Inducement Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of May 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 18:52 UTC
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $3.94 $0.00
Disclosure

SEC source: 0001861684-26-000005 · form4-03162026_100309.xml · derivative · entry 2

Young Joseph R · CIK 0001861684 · SVP, FINANCE, CHIEF ACCT OFFCR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,589

Underlying: Class A Common Stock · 10,000 shares

Expires 2031-04-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 18:52 UTC
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
Exercise / conversionClass A Common Stock 10,000 $3.94 $39,396.00
Disclosure

SEC source: 0001861684-26-000005 · form4-03162026_100309.xml · nonDerivative · entry 1

Young Joseph R · CIK 0001861684 · SVP, FINANCE, CHIEF ACCT OFFCR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,032 shares acquired pursuant to the Company's 2021 Employee Stock Purchase Plan.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 20:49 UTC GrantStock Option (right to buy) · Derivative 24,937 $0.00 Strike: $38.85 $0.00
Disclosure

SEC source: 0001814238-26-000005 · form4-03092026_080317.xml · derivative · entry 1

Hite Christopher · CIK 0001814238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,937

Underlying: Class A Common Stock · 24,937 shares

Expires 2036-03-04

F1 · derivative.exercise_date: The shares subject to the option will vest monthly over a three-year period, subject to the Reporting Person's continuous service on each vesting date.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 20:01 UTC
Brenner RobertChief Medical Officer
SaleClass A Common Stock 2,151 $41.98 $90,307.37
Disclosure

SEC source: 0002006910-26-000004 · form4-02262026_010204.xml · nonDerivative · entry 1

Brenner Robert · CIK 0002006910 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,947

F1 · date: The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026.

F2 · kind: Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 20:00 UTC
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
SaleClass A Common Stock 3,117 $41.98 $130,863.82
Disclosure

SEC source: 0001861684-26-000004 · form4-02262026_010213.xml · nonDerivative · entry 1

Young Joseph R · CIK 0001861684 · SVP, FINANCE, CHIEF ACCT OFFCR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,722

F1 · date: The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026.

F2 · kind: Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.